Chondrochymal® for Subjects With Knee Osteoarthritis (Knee OA)
Status:
Recruiting
Trial end date:
2024-09-10
Target enrollment:
Participant gender:
Summary
This is a randomized, single-blind, parallel, active-controlled study to evaluate the
efficacy and safety of bone marrow mesenchymal stem cells (BM-MSCs), Chondrochymal®, in
subjects aged 40 to 80 with knee OA.